chronic atrophic gastritis
Conditions
Interventions
chronic atrophic gastritis:no
chronic Non-Atrophic Gastritis:no
gastric adenocarcinoma:no
Precancerous lesions of gastric cancer:no
Sponsors
GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE,HAINAN HOSPITAL
Eligibility
Sex/Gender
All
Age
35 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1)Age over 35 years old gender is not limited. 2) The disease diagnosis of chronic non-atrophic gastritis chronic atrophic gastritis gastric precancerous lesion gastric adenocarcinoma is clearly defined by gastroscopy and pathological histological examination of gastric mucosa. 3)Can carry out normal verbal communication and exchange. 4)Informed consent and volunteer to be tested.
Exclusion criteria
Exclusion criteria: 1) Receiving drug therapy study within the last 1 month. 2) Combined autoimmune gastritis (type A chronic atrophic gastritis) peptic ulcer (stage A1-H2) reflux oesophagitis gastric polyp hypertrophic gastritis ulcerative colitis and other diseases. 3) Those with non-gastric adenocarcinoma such as gastric ring cell carcinoma cardia carcinoma gastric mucous cell carcinoma etc. 4)Malignant tumours for which surgery radiotherapy and chemotherapy have been performed within the last 5 years. 5)Combined serious organic diseases. For example: heart (cardiac function NYH class III-IV haemodynamically unstable myocardial infarction etc.) liver (cirrhosis decompensated stage etc.) kidney (chronic renal failure uremic stage etc.) lungs (tuberculosis acute asthma attacks lung infections etc.) autoimmune system (systemic lupus erythematosus in active stage). 6)Allergies or hypersensitivity to multiple medications. 7)Those with comorbid serious mental illnesses that are unable to cooperate with the study such as schizophrenia depression anxiety disorders and dementia. 8)Pregnant breastfeeding women 9)Investigate non-cooperators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TCM syndrome information;Gastroscope Report;Pathological Report;Key molecular markers(circ4928miR615-5pSST); | — |
Secondary
| Measure | Time frame |
|---|---|
| Epidemiological information;Prognostic information; | — |
Countries
China
Contacts
Public ContactPanJinglin
GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE,HAINAN HOSPITAL
Outcome results
None listed